Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 4
2019 11
2020 10
2021 14
2022 13
2023 12
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Results by year

Filters applied: . Clear all
Page 1
Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell and tumor-localized IL-12 immunotherapy.
Bhatia V, Kamat NV, Pariva TE, Wu LT, Tsao A, Sasaki K, Sun H, Javier G, Nutt S, Coleman I, Hitchcock L, Zhang A, Rudoy D, Gulati R, Patel RA, Roudier MP, True LD, Srivastava S, Morrissey CM, Haffner MC, Nelson PS, Priceman SJ, Ishihara J, Lee JK. Bhatia V, et al. Nat Commun. 2023 Apr 11;14(1):2041. doi: 10.1038/s41467-023-37874-2. Nat Commun. 2023. PMID: 37041154 Free PMC article.
Editorial Comment.
Gulati R, Nyame YA. Gulati R, et al. J Urol. 2022 Nov;208(5):1027. doi: 10.1097/JU.0000000000002835.04. Epub 2022 Sep 6. J Urol. 2022. PMID: 36065679 No abstract available.
Reducing Prostate Cancer Overdiagnosis.
Gulati R. Gulati R. N Engl J Med. 2022 Dec 8;387(23):2187-2188. doi: 10.1056/NEJMe2214658. N Engl J Med. 2022. PMID: 36477037 No abstract available.
Reversible epigenetic alterations mediate PSMA expression heterogeneity in advanced metastatic prostate cancer.
Sayar E, Patel RA, Coleman IM, Roudier MP, Zhang A, Mustafi P, Low JY, Hanratty B, Ang LS, Bhatia V, Adil M, Bakbak H, Quigley DA, Schweizer MT, Hawley JE, Kollath L, True LD, Feng FY, Bander NH, Corey E, Lee JK, Morrissey C, Gulati R, Nelson PS, Haffner MC. Sayar E, et al. JCI Insight. 2023 Apr 10;8(7):e162907. doi: 10.1172/jci.insight.162907. JCI Insight. 2023. PMID: 36821396 Free PMC article.
Reply by Authors.
Schweizer MT, True L, Gulati R, Zhao Y, Ellis W, Schade G, Montgomery B, Goyal S, Nega K, Hakansson AK, Liu Y, Davicioni E, Pienta K, Nelson PS, Lin D, Wright J. Schweizer MT, et al. J Urol. 2023 Feb;209(2):362-363. doi: 10.1097/JU.0000000000003038.02. Epub 2023 Feb 1. J Urol. 2023. PMID: 36621992 No abstract available.
When Clinical Trials Disagree.
Etzioni R, Gulati R. Etzioni R, et al. J Urol. 2018 Sep;200(3):506-507. doi: 10.1016/j.juro.2018.02.3084. Epub 2018 Mar 1. J Urol. 2018. PMID: 29496471 No abstract available.
Reply by Authors.
Gulati R, Psutka SP, Etzioni R. Gulati R, et al. J Urol. 2019 Nov;202(5):943. doi: 10.1097/01.JU.0000578960.95038.28. Epub 2019 Oct 9. J Urol. 2019. PMID: 31364930 No abstract available.
Prostate cancer screening in African American men: a review of the evidence.
Kensler KH, Johnson R, Morley F, Albrair M, Dickerman BA, Gulati R, Holt SK, Iyer HS, Kibel AS, Lee JR, Preston MA, Vassy JL, Wolff EM, Nyame YA, Etzioni R, Rebbeck TR. Kensler KH, et al. J Natl Cancer Inst. 2024 Jan 10;116(1):34-52. doi: 10.1093/jnci/djad193. J Natl Cancer Inst. 2024. PMID: 37713266 Review.
62 results